These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 29504046)
1. Advances in Drug Discovery and Development in Geriatric Psychiatry. C Conley A; A Newhouse P Curr Psychiatry Rep; 2018 Mar; 20(2):10. PubMed ID: 29504046 [TBL] [Abstract][Full Text] [Related]
2. [Psychopharmacology in the psychogeriatric domain: current data, problems, perspectives]. Lima CA; Eap CB; Baumann P Rev Med Suisse Romande; 2000 Feb; 120(2):131-6. PubMed ID: 10748699 [No Abstract] [Full Text] [Related]
3. Drug discovery in psychopharmacology: from 2D models to cerebral organoids . Rossetti AC; Koch P; Ladewig J Dialogues Clin Neurosci; 2019; 21(2):203-224. PubMed ID: 31636494 [TBL] [Abstract][Full Text] [Related]
4. Back to the future of psychopharmacology: A perspective on animal models in drug discovery. Hendriksen H; Groenink L Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259 [TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation in geriatric psychopharmacology. The point of view of the pharmaceutical industry]. Loew DM Presse Med; 1983 Dec; 12(48):3141-6. PubMed ID: 6228929 [TBL] [Abstract][Full Text] [Related]
6. Redirecting the revolution: new developments in drug development for psychiatry. Brady LS; Potter WZ; Gordon JA Expert Opin Drug Discov; 2019 Dec; 14(12):1213-1219. PubMed ID: 31545131 [No Abstract] [Full Text] [Related]
7. Failed drug discovery in psychiatry: time for human genome-guided solutions. Papassotiropoulos A; de Quervain DJ Trends Cogn Sci; 2015 Apr; 19(4):183-7. PubMed ID: 25727774 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology in cross-cultural psychiatry. Lin KM Mt Sinai J Med; 1996; 63(5-6):283-4. PubMed ID: 8898528 [No Abstract] [Full Text] [Related]
10. Opportunities and challenges in psychopharmacology . Schulz P Dialogues Clin Neurosci; 2019; 21(2):119-130. PubMed ID: 31636486 [TBL] [Abstract][Full Text] [Related]
11. Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road. Kadriu B; Musazzi L; Johnston JN; Kalynchuk LE; Caruncho HJ; Popoli M; Zarate CA Drug Discov Today; 2021 Dec; 26(12):2816-2838. PubMed ID: 34358693 [TBL] [Abstract][Full Text] [Related]
12. Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue? Drukarch B; Jacobs GE; Wilhelmus MMM Biomed Pharmacother; 2020 Oct; 130():110545. PubMed ID: 32731134 [TBL] [Abstract][Full Text] [Related]
13. SPET in psychopharmacology. Moresco RM; Fazio F Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):205-14. PubMed ID: 16010255 [TBL] [Abstract][Full Text] [Related]
14. Geriatric psychopharmacology: evolution of a discipline. Meyers BS; Jeste DV J Clin Psychiatry; 2010 Nov; 71(11):1416-24. PubMed ID: 21114947 [TBL] [Abstract][Full Text] [Related]
15. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases. Van der Schyf CJ Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127 [TBL] [Abstract][Full Text] [Related]
16. Revitalizing psychiatric drug discovery. Sarter M; Tricklebank M Nat Rev Drug Discov; 2012 Jun; 11(6):423-4. PubMed ID: 22653200 [TBL] [Abstract][Full Text] [Related]
18. Clinical psychopharmacology: advances and challenges from 1965 to 2006. Crismon ML Ann Pharmacother; 2006 Sep; 40(9):1649-50. PubMed ID: 16896024 [No Abstract] [Full Text] [Related]